These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 36742277

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
    Hofste Op Bruinink D, Kuiper R, van Duin M, Cupedo T, van der Velden VHJ, Hoogenboezem R, van der Holt B, Beverloo HB, Valent ET, Vermeulen M, Gay F, Broijl A, Avet-Loiseau H, Munshi NC, Musto P, Moreau P, Zweegman S, van de Donk NWCJ, Sonneveld P.
    J Clin Oncol; 2022 Sep 20; 40(27):3132-3150. PubMed ID: 35357885
    [Abstract] [Full Text] [Related]

  • 24. [A primitive plasma cell leukemia with immunoglobulin (Ig) E].
    Rachidi M, Lazarian G, Letestu R, Lusina D, Desbene C, Vidal V, Eclache V, Baran-Marszak F, Cymbalista F, Fleury C.
    Ann Biol Clin (Paris); 2019 Oct 01; 77(5):557-561. PubMed ID: 31512579
    [Abstract] [Full Text] [Related]

  • 25. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
    Gangadhar P, Ahmed Z, Pai MR, Sandhya I.
    Indian J Pathol Microbiol; 2016 Oct 01; 59(4):541-544. PubMed ID: 27721294
    [Abstract] [Full Text] [Related]

  • 26. Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.
    Zatula A, Dikic A, Mulder C, Sharma A, Vågbø CB, Sousa MML, Waage A, Slupphaug G.
    Oncotarget; 2017 Mar 21; 8(12):19427-19442. PubMed ID: 28038447
    [Abstract] [Full Text] [Related]

  • 27. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
    Todoerti K, Agnelli L, Fabris S, Lionetti M, Tuana G, Mosca L, Lombardi L, Grieco V, Bianchino G, D'Auria F, Statuto T, Mazzoccoli C, De Luca L, Petrucci MT, Morabito F, Offidani M, Di Raimondo F, Falcone A, Omede' P, Tassone P, Boccadoro M, Palumbo A, Neri A, Musto P.
    Clin Cancer Res; 2013 Jun 15; 19(12):3247-58. PubMed ID: 23599371
    [Abstract] [Full Text] [Related]

  • 28. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
    An G, Qin X, Acharya C, Xu Y, Deng S, Shi L, Zang M, Sui W, Yi S, Li Z, Hao M, Feng X, Jin F, Zou D, Qi J, Zhao Y, Tai YT, Wang J, Qiu L.
    Ann Hematol; 2015 Feb 15; 94(2):257-64. PubMed ID: 25231928
    [Abstract] [Full Text] [Related]

  • 29. Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From India.
    Yadav N, Aggarwal M, Mehta P, Kapoor J, Thekkudan SF, Bhandari P, Soni P, Ahmed R, Bhurani D, Agrawal N.
    Indian J Hematol Blood Transfus; 2019 Oct 15; 35(4):649-654. PubMed ID: 31741616
    [Abstract] [Full Text] [Related]

  • 30. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
    Li F, Gao YJ, Li SS, Xi YY, Yang XW, Su YH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec 15; 31(6):1771-1779. PubMed ID: 38071059
    [Abstract] [Full Text] [Related]

  • 31. [Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia].
    Dou XL, Liu RX, Liu Y, Peng N, Wen L, Wu Y, Li Q, Zhong YP, Zhou X, Liao AJ, Jiang HN, Ma XJ, Dong HH, Fan SJ, Zhao YQ, Hu DH, Lu J.
    Zhonghua Yi Xue Za Zhi; 2024 Feb 20; 104(7):499-506. PubMed ID: 38317361
    [Abstract] [Full Text] [Related]

  • 32. Primary Plasma Cell Leukemia: Identity Card 2016.
    Musto P, Simeon V, Todoerti K, Neri A.
    Curr Treat Options Oncol; 2016 Apr 20; 17(4):19. PubMed ID: 26995215
    [Abstract] [Full Text] [Related]

  • 33. Plasma cell leukemia.
    Albarracin F, Fonseca R.
    Blood Rev; 2011 May 20; 25(3):107-12. PubMed ID: 21295388
    [Abstract] [Full Text] [Related]

  • 34. Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?
    Suska A, Vesole DH, Castillo JJ, Kumar SK, Parameswaran H, Mateos MV, Facon T, Gozzetti A, Mikala G, Szostek M, Mikhael J, Hajek R, Terpos E, Jurczyszyn A.
    Clin Hematol Int; 2020 Dec 20; 2(4):133-142. PubMed ID: 34595454
    [Abstract] [Full Text] [Related]

  • 35. [The clinical characteristics of patients with primary plasma cell leukemia and the efficacy of novel agents and hematopoietic stem cell transplantation].
    Li WJ, Wang FR, Wen L, Chen Y, Chen H, Huang XJ, Lu J.
    Zhonghua Nei Ke Za Zhi; 2020 Oct 01; 59(10):801-806. PubMed ID: 32987483
    [Abstract] [Full Text] [Related]

  • 36. Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
    Mina R, Joseph NS, Kaufman JL, Gupta VA, Heffner LT, Hofmeister CC, Boise LH, Dhodapkar MV, Gleason C, Nooka AK, Lonial S.
    Cancer; 2019 Feb 01; 125(3):416-423. PubMed ID: 30332496
    [Abstract] [Full Text] [Related]

  • 37. Plasma cell leukemia: a report on 15 patients.
    Bernasconi C, Castelli G, Pagnucco G, Brusamolino E.
    Eur J Haematol Suppl; 1989 Feb 01; 51():76-83. PubMed ID: 2697596
    [Abstract] [Full Text] [Related]

  • 38. Causes of death in primary plasma cell leukemia differ from multiple myeloma: A STROBE-compliant descriptive study based on SEER database.
    Ge X, Meng W, Wang W, Ma H, Zhao S, Cui K.
    Medicine (Baltimore); 2022 Jul 22; 101(29):e29578. PubMed ID: 35866755
    [Abstract] [Full Text] [Related]

  • 39. Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols.
    Usmani SZ, Nair B, Qu P, Hansen E, Zhang Q, Petty N, Waheed S, Shaughnessy JD, Alsayed Y, Heuck CJ, van Rhee F, Milner T, Hoering A, Szymonifka J, Sexton R, Sawyer J, Singh Z, Crowley J, Barlogie B.
    Leukemia; 2012 Nov 22; 26(11):2398-405. PubMed ID: 22508408
    [Abstract] [Full Text] [Related]

  • 40. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles.
    Mosca L, Musto P, Todoerti K, Barbieri M, Agnelli L, Fabris S, Tuana G, Lionetti M, Bonaparte E, Sirchia SM, Grieco V, Bianchino G, D'Auria F, Statuto T, Mazzoccoli C, De Luca L, Petrucci MT, Morabito F, Offidani M, Di Raimondo F, Falcone A, Caravita T, Omedè P, Boccadoro M, Palumbo A, Neri A.
    Am J Hematol; 2013 Jan 22; 88(1):16-23. PubMed ID: 23044976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.